Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Life Sciences
|
October 11, 2003
Endothelial modulation and tolerance development in the vasorelaxant responses to nitrate of rabbit aorta
Ichiro Nakae, Tetsuya Matsumoto, Tomoko Omura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 5, 2014
A novel HCN4 mutation, G1097W, is associated with atrioventricular block
Jun Zhou, Wei-Guang Ding, Takeru Makiyama, et al.
Heart and Vessels
|
April 29, 2014
Development of new risk score for pre-test probability of obstructive coronary artery disease based on coronary CT angiography
Shinichiro Fujimoto, Takeshi Kondo, Hideya Yamamoto, et al.
Circulation. Cardiovascular Interventions
|
May 8, 2014
Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial
Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Journal of the American Heart Association
|
July 2, 2018
Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials
Hiroki Watanabe, Takeshi Morimoto, Hiroki Shiomi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 6, 2017
Second-Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions - Pooled Analysis From the RESET and NEXT Trials
Koji Nishida, Kenji Nakatsuma, Hiroki Shiomi, et al.
Circulation. Cardiovascular Interventions
|
October 9, 2015
Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.
Journal of the American College of Cardiology
|
May 21, 2013
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial
Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions
|
April 6, 2019
7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial
Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 7, 2023
Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study
Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Life Sciences
|
October 11, 2003
Endothelial modulation and tolerance development in the vasorelaxant responses to nitrate of rabbit aorta
Ichiro Nakae, Tetsuya Matsumoto, Tomoko Omura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 5, 2014
A novel HCN4 mutation, G1097W, is associated with atrioventricular block
Jun Zhou, Wei-Guang Ding, Takeru Makiyama, et al.
Heart and Vessels
|
April 29, 2014
Development of new risk score for pre-test probability of obstructive coronary artery disease based on coronary CT angiography
Shinichiro Fujimoto, Takeshi Kondo, Hideya Yamamoto, et al.
Circulation. Cardiovascular Interventions
|
May 8, 2014
Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial
Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Journal of the American Heart Association
|
July 2, 2018
Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials
Hiroki Watanabe, Takeshi Morimoto, Hiroki Shiomi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 6, 2017
Second-Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions - Pooled Analysis From the RESET and NEXT Trials
Koji Nishida, Kenji Nakatsuma, Hiroki Shiomi, et al.
Circulation. Cardiovascular Interventions
|
October 9, 2015
Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.
Journal of the American College of Cardiology
|
May 21, 2013
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial
Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions
|
April 6, 2019
7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial
Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 7, 2023
Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study
Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Page
of 3